PET-CT in Precision Medicine
Corresponding author: [email protected]
Abstract
Precision medicine takes account of individual variability in genes, environment and lifestyle. In oncology two tumours of the same organ and histology can carry different molecular targets and respond differently to the same drug, so treatment chosen for the individual tumour requires measurements made on that individual. Biopsy samples a few cubic millimetres of tissue at one time point, whereas imaging samples the whole body and can be repeated. CT and MRI describe structure; positron emission tomography describes function — glucose consumption, receptor density, enzyme activity — and combined with CT in one gantry it places a functional map on an anatomical one. This chapter covers the development of PET and combined PET-CT, the physical principles of positron decay and coincidence detection, radionuclides and tracers, quantification by the standardised uptake value, patient preparation and the examination, the role of PET-CT in precision medicine, and radiation dose and safety.
Author Affiliations
- 1 Scholar, Saraswati College of Pharmacy, SGC Group, Gharuan 140413, Mohali, Punjab, India.